Allakos Investigational Site

San Antonio, Texas 78229

0 studies enrolling now · 3 studies all time

What they study most

Eosinophilic Duodenitis, Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Gastroenteritis

Studies at this site

• A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis — Completed
• A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis — Completed
• A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis — Withdrawn before enrolling